The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global protein detection & quantification market reached a value of US$ 2.25 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.05 Billion by 2027 exhibiting a CAGR of 9.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Protein detection and quantification refer to methods that are generally adopted by scientific experts in order to determine the total protein content and its characteristics. It helps to develop a comparison between two distinctive protein samples, measure enzyme kinetics, and verify the success of the lysis step. Some of the commonly used techniques for protein detection and quantification include enzyme-linked immunosorbent assay (ELISA), mass spectrometry, western blot analysis and nanoparticles and nanopore-based methods. As a result, it is extensively utilized across academic institutions, research organizations, and biotechnology and pharmaceutical companies for research studies and clinical diagnosis.
The global market is primarily driven by significant growth in the pharmaceutical industry. Along with this, various technological advancements in biotechnology are acting as major growth-inducing factors. For instance, the widespread adoption of infrared spectroscopy and immunoassay techniques that assist experts in attaining accurate results is expected to impact the market growth favorably. Moreover, increasing investments by private and public agencies to conduct extensive research and development (R&D) in the field of proteomics is one of the key factors driving the growth of the market across the globe. Furthermore, the rising prevalence of chronic illnesses that have propelled the need to diagnose diseases at a molecular level in order to develop therapeutic treatments is providing a boost to the market growth on the global level. Other factors, including the increasing investments to upgrade the existing healthcare infrastructure and continuous improvements in the genomics industry, are also projected to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein detection & quantification market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end user.
Breakup by Product:
Breakup by Technology:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, General Electric Company, Inanovate Inc., Merck KGaA, PerkinElmer Inc., RayBiotech Life Inc., Shimadzu Corporation and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Technology, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, General Electric Company, Inanovate Inc., Merck KGaA, PerkinElmer Inc., RayBiotech Life Inc., Shimadzu Corporation and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at